REVB News - Candlesense

Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2025

SAN DIEGO--(BUSINESS WIRE)---- $REVB #AKI--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on rebalancing inflamm...

What are the potential risks or upside scenarios associated with the Gemini program's progression? Did the company disclose any partnership, licensing, or collaboration agreements that could affect future revenue streams? What is the burn rate and expected cash consumption rate moving forward?

Earnings

23 days ago